Ipsen - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Ipsen Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Ipsen. The Group's principal activity is to develop and distribute pharmaceutical products. The Group develops innovative drugs used in therapeutic areas in oncology, endocrinology and neuromuscular disorders. Some of their products include Decapeptyl, Somatuline, NutropinAq, Autogel, Forlax, Tanakan, Testim and Dysport. The Group also offers products on primary care which includes the areas of gastroenterology, cardiovascular and cognitive disorders. The Group operates throughout the world, In 2008, the Group acquired Vernalis Pharmaceuticals and Tercica Inc.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report